IP Library Granted Patent US 7,820,396
Granted Patent B2
US 7,820,396 · App. 12/090,644 · Granted Oct 26, 2010

Method for determining atopic dermatitis using protein marker

Assignees: Fancl Corporation; Kaoru Miyazki; Zentro Ikezawa; Michiko Aihara; Kayano Moriyama
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,820,396
App. No.
12/090,644
Granted
Oct 26, 2010
Kind
B2
Abstract

It is an object of the present invention to find substances that can be used as disease markers for atopic dermatitis and the present invention provides a method for determining atopic dermatitis, including measurement of the expression of specific proteins and/or their genes in skin cells and/or skin tissues, wherein the specific proteins change their expression with inflammation caused by atopic dermatitis or change their expression according to the degree of predisposition to atopic dermatitis. The present invention also provides a kit for determining the degree of inflammation of atopic dermatitis or risk of developing atopic dermatitis, as well as a method for determining substances effective in the treatment and/or prevention of atopic dermatitis.

Claims (4)

1. A method for determining atopic dermatitis, comprising measurement of the expression of a protein in skin cells and/or skin tissues, wherein the protein changes its expression with inflammation caused by atopic dermatitis, wherein the protein is Annexin II.

2. A method for determining atopic dermatitis, comprising measurement of the expression of a protein in skin cells and/or skin tissues, wherein the protein changes its expression with inflammation caused by atopic dermatitis, wherein the protein is Apolipoprotein A1.

3. The method according to claim 2 , wherein the skin cells and/or skin tissues are those of the skin's horny cell layer collected using a horny cell layer checker.

4. A method for determining atopic dermatitis, comprising measurement of the expression of proteins in skin cells and/or skin tissues, wherein the proteins change their expression with inflammation caused by atopic dermatitis, wherein the proteins are Annexin II, SCCA2, and Apolipoprotein A1.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2008
From: YOKOHAMA CITY UNIVERSITY
To: MIYAZAKI, KAORU; IKEZAWA, ZENRO; AIHARA, MICHIKO; MORIYAMA, KAYANO
Reel/Frame 021156/0844 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2008
From: KIHARA MEMORIAL YOKOHAMA FOUNDATION FOR THE ADVANCEMENT OF LIFE SCIENCES; KIRIN HOLDINGS KABUSHIKI KAISHA
To: FANCL CORPORATION
Reel/Frame 021156/0912 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2008
From: MIYATA, SATOSHI; MIYAZAKI, KAORU; YASUDA, CHIE; IWAMATSU, AKIHIRO; IKEZAWA, ZENRO; AIHARA, MICHIKO; MORIYAMA, KAYANO
To: FANCL CORPORATION; YOKOHAMA CITY UNIVERSITY; KIHARA MEMORIAL YOKOHAMA FOUNDATION FOR THE ADVANCEMENT OF LIFE SCIENCES; KIRIN HOLDINGS KABUSHIKI KAISHA
Reel/Frame 020840/0921 →
Priority Claims (1)
JP 2005-306498 · Oct 21, 2005 · national
Continuity (1)
Related Publication 20090263792A1 · Oct 22, 2009